APM
ABMD

Avidity Partners Management’s Abiomed Inc ABMD Stock Holding History

Avidity Partners Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-132,500
Closed -$42.2M – 142
2021
Q1 		$42.2M Buy
+132,500
New +$42.4M 1.17% 31

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Avidity Partners Management's ABMD Position: Q2 2021 in Review

Avidity Partners Management sold out of Abiomed Inc (ABMD) in Q2 2021, closing a stake of 132,500 shares — an estimated $42.2M sold.

Avidity Partners Management first reported a position in ABMD in Q1 2021 and held it in 1 quarter. The position peaked at $42.2M in Q1 2021. 474 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

  • Avidity Partners Management reported no remaining Abiomed Inc position as of Q2 2021 after selling out during the quarter.
  • Avidity Partners Management sold 132,500 Abiomed Inc shares in Q2 2021, an estimated $42.2M.
  • Avidity Partners Management first reported a position in Abiomed Inc in Q1 2021 and held it in 1 quarter.
  • Avidity Partners Management's Abiomed Inc position peaked at $42.2M in Q1 2021.
  • 474 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on Avidity Partners Management's 13F filing for Q2 2021, filed 16 Aug 2021.